Objectives: Recent evidence indicates that reactive oxygen species (ROS) may act as second messengers in receptor-mediated signaling pathways. The possible role of ROS during Et-1 stimulation in cardiomyocytes was therefore investigated. Methods: Intracellular ROS levels were measured with fluorescence probe 29,79-dichlorofluorescin diacetate by confocal microscopy in cultured neonatal rat cardiomyocytes. The ROS-inducible c-fos expression was analyzed by Northern blotting and promoter activity. Results: Et-1 applied to cardiomyocytes dose-dependently increased intracellular ROS levels. The increase of ROS levels was attenuated by pretreating cardiomyocytes with Et-A receptor antagonist-BQ485, but not with Et-B receptor antagonist. Cardiomyocytes pretreated with catalase or an antioxidant N-acetylcysteine (NAC) reduced Et-1-induced ROS levels. Et-1 or H O treatment of cardiomyocytes rapidly induced the with catalase or NAC. Cells transiently transfected with the dominant positive mutant of p21 (RasL61) led to a significant increase in intracellular ROS. Concomitantly, the mRNA levels and the promoter activities of c-fos were also induced. In contrast, cells transfected with the dominant negative mutant of Ras (RasN17) inhibited Et-1-induced ROS. Consistently, the increase of c-fos mRNA levels and promoter activities by Et-1 were also inhibited. Conclusions: These findings clearly indicate that Et-1 treatment to cardiomyocytes can induce ROS via Ras pathway and the increased ROS are involved in the increase of c-fos expression. Our studies thus emphasize the importance of ROS as second messengers in Et-1-induced responses in cardiomyocytes.
Introduction
early growth response-1 (egr-1 ) [4] . It has been reported that Et-1 activates a phosphorylation cascade of protein Endothelin-1 (Et-1) is a potent 21-amino acid long kinases including Raf-1 and the extracellular signal-regvasopressor secreted from endothelial cells [1] . Apart from ulated kinase (ERK) of the mitogen-activated protein its constrictive activity on vascular smooth muscle, Et-1 kinase (MAPK) signaling pathway in cardiac myocytes has been demonstrated to stimulate hypertrophic growth in [3] . Et-1 also activates phosphorylation cascade of MAPK / cardiomyocytes [2, 3] . Et-1 can induce a transient increase Jun amino-terminal kinase (JNK) in cardiac myocytes in expression of immediate early genes including c-fos and [5, 6] . Both ERK and JNK can phosphorylate Elk-1, one of several ternary complex factors, and resulting in an increase of c-fos transcription [7] [8] [9] . c-fos and c-jun make the heterodimer complex of activating protein-1 (AP-1), which preferentially binds to many genes that have 12-Owere prepared as previously described [2] . The rats were tetradecanoylphorbol-13-acetate (TPA)-responsive element handled in accordance with the Guide for the Care and (TRE) in their promoter region [10] .
Use of Laboratory Animals published by the US National Recent evidence indicates that reactive oxygen species
Institutes of Health (NIH Publication No. 85-23, revised (ROS) may function as intracellular messengers to modu-1985) . Briefly, ventricles from 1-to 2-day-old neonatal late signaling pathways [11] . ROS encompass many oxySprague-Dawley rats were cut into chunks of approxi- 3 gen species including singlet oxygen, superoxide, hydromately 1 mm using scissors and subjected to trypsin gen peroxide (H O ) and hydroxyl radicals that are (0.125%, Gibco) digestion in phosphate-buffered saline 2 2 produced by virtually every type of cell [12] . ROS, when (PBS). Trypsin digested cells were collected by centrifugapresent in excess, are toxic to cells due to the potential tion at 1200 rpm for 5 min. The cell pellet was redamage they can cause to cellular components. However, suspended in a medium containing 80% F10 nutrient there is growing evidence that ROS at low concentration mixture, 20% fetal calf serum, penicillin (100 U / ml) and serve as signaling molecules, providing a chemical link streptomycin (68.6 mmol / l) and plated into a petri dish for between alterations in intracellular redox status and re-2.5 h. The suspended nonattached myocytes in the medium sponsive changes in the structure and function of transcripwere collected and plated on a 100-mm diameter culture 7 tion factors [12] . The changes of intracellular ROS have dishes with cell density at 1?10 cells / dish. After 2 days in been detected in a variety of cells stimulated with cytoculture, cells were transferred to medium containing 90% kines, growth factors, agonists of receptor [12] . Studies DMEM nutrient mixture, 10% fetal calf serum, penicillin have also demonstrated that Et-1 treatment can induce (100 U / ml) and streptomycin (68.6 mmol / l). Myocytes ROS levels in various cells [13, 14] . However, the origin of cultures thus obtained were .80% pure as revealed by ROS and their signaling roles contributing to cellular their contractile characteristics under light microscopy. responses in cardiomyocytes have not been well characterSerum-containing medium from these cultured myocytes ized.
was replaced with serum-free medium and exposed to ras The small G protein p21 (Ras) is a potent regulator of agents as indicated. For measurement of intracellular ROS myogenic cell growth and differentiation. Ras has been generation, cardiomyocytes were plated to 30-mm diam-4 demonstrated to play a role in Et-1-mediated c-fos activity eter culture dishes with low cell density (|1?10 cells / in cardiomyocytes [15] . Ras has been implicated to play a dish) to monitor intracellular oxidation in single carmajor role in the genesis of cardiac hypertrophy by diomyocyte. activating the Raf-1 / ERK pathway [16, 17] . It has been reported that Ras contributes to the induction of the c-fos 2.3. Transfections by Et-1 in mesangial cells [18] . Recent findings further indicate that Ras is involved in the ROS generation in For the transient transfections, cardiac cells were transfibroblasts [19, 20] . Furthermore, Et-1 has also been refected with different expression vectors by the calcium ported to increase the ROS levels in broncho-alveolar cells phosphate method [23] . The DNA-CaPO precipitates in 4 [13] . The c-fos gene has been shown to be induced by Et-1 each dish (10 ml) contained the following if not spe- [21] or oxidants [22] Intracellular ROS production was measured by using a The chloramphenicol acetyltransferase (CAT) and bfluorescent dye, 29,79-dichlorofluorescin diacetate (DCFgalactosidase assays were performed as previously de-DA) (Molecular Probes, Eugene, OR, USA) with the scribed [2] . The relative CAT activity was corrected by ACAS Interactive Laser Cytometer (Meridian Instruments, normalizing the respective CAT value to that of b-galactoOkemos, MI, USA). DCF-DA is a membrane-permeable sidase activity. Cotransfected b-galactosidase activity varcompound. After intracellular deacetylation, DCF-DA ied by ,10% within a given experiment and was not forms a nonfluorescent product (DCF), which upon oxidaaffected by any of the experimental manipulations detion is transformed into fluorescent DCF [26] . A 10 mmol / scribed. As positive and negative controls, pBLCAT2 (with l stock solution of DCF-DA was prepared in ethanol on a thymidine kinase promoter) and pBLCAT3 (without prodaily basis and diluted to a final concentration of 10 moter) were included in every assay [23] . mmol / l just before the experiments. Myocytes with or without transfection were preincubated with 10 mmol / l 2.7. Statistical analysis DCF-DA in DMEM for 30 min at 378C prior to treatment. Cells after dye exposure were rinsed with normal Tyrode Data were presented as mean6S.E.M. Statistical analysolution. The cells were maintained in normal Tyrode sis was performed using one-way analysis of variance solution and examined with the Laser Cytometer at 378C.
(ANOVA) or an unpaired Student's t-test. The significance Excitation of DCF was achieved using the 488-nm line of level a was set at 0.05. a 20-mW argon-ion laser. The emission above 515-nm is quantitated from two dimensional image scans generated by a 1 micron laser beam and an X-Y scanning stage. A 3. Results fluorescence value from single cells can be obtained. To provide a valid comparison, the same acquisition parame-3.1. Et-1 induced intracellular ROS levels in ters were used for all observations. Quantification of the cardiomyocytes levels of DCF fluorescence was assessed on a relative scale from 0-4000 units. Baseline values from unstimulated or Intracellular generation of ROS in cardiomyocytes was pSRa-tranfected cells were used as control values to analyzed by the fluorescent product (DCF), a peroxidative compare with Et-1-stimulated or Ras-transfected cells.
product of DCF-DA with laser-scanning confocal microValues represent means6S.E.M. of DCF fluorescence from scopy. Exposure of cardiomyocytes to Et-1 (10 nmol / l) at least 20 randomly selected cells. This experiment was rapidly induced DCF fluorescence with a maximal increase repeated for at least six times to avoid the transfection of 2-fold at 15 min after stimulation (Fig. 1) . This ROS variation.
induction was shown to be an Et-1 concentration dependent since ROS level appeared to reach plateau after 2.5. RNA isolation and northern hybridization treating with 10 nmol / l of Et-1 ( Fig. 2A) . To specify which Et-1 receptor subtype that was responsible for the Total RNA was obtained by using guanidine thiocyanate generation of ROS in cardiomyocytes, we pretreated as described previously [2] . Total RNA was collected and cardiomyocytes with Et-1 receptor type A antagonist examined by mini-gel agarose electrophoresis. Ten micro-(BQ485) or receptor type B antagonist (BQ788) before the grams of RNA was mixed with loading buffer containing Et-1 exposure. As shown in Fig. 2B , BQ485 (100 nmol / l) ethidium bromide. The sample mixture was loaded and significantly inhibited the Et-1-induced generation of ROS. separated on 1% agarose gels containing 3.7% formaldeIn contrast, BQ788 (100 nmol / l) had no significant effect hyde. RNA was transferred onto Nytran membrane on Et-1-induced generation of ROS. These results suggest (Schleicher & Schuell, Germany) by a vacuum blotting that an increase of intracellular ROS levels upon Et-1 system (VacuGene XL, Pharmacia, Sweden) and immobiltreatment is mediated mainly through the binding of Et-1 ized by ultraviolet irradiation. A 2137 bp EcoR I / EcoR I to Et-1 receptor type A. fragment containing rat c-fos DNA [27] was used as the To examine whether the ROS were responsible for the c-fos probe and was labeled by random priming with oxidation of DCF in cardiomycytes, we examined whether catalase, an enzyme that specifically hydrolyses H O , was The c-fos mRNA levels were shown by Northern blotting 2 2 able to prevent the oxidation of DCF. Cardiomyocytes at various time intervals after treating cardiomyocytes with were treated with Et-1 in the presence of catalase (350 either Et-1 (10 nmol / l) or H O (25 mmol / l) (Fig. 3) . As 2 2 U / ml). The addition of catalase to cultured carshown, the serum-deprived cultured cardiomyocytes incudiomyocytes completely inhibited Et-1-induced ROS levels bated with Et-1 (10 nmol / l) rapidly increased c-fos mRNA as measured at 15 min after Et-1 treatment (Fig. 2B) . levels within 10 min of Et-1 exposure. This induction NAC, a glutathione precursor and a free radical scavenger, reached a maximal level at 30 min, i.e., an 11-fold also inhibited the increase in Et-1-induced intracellular induction vs. control cells (Fig. 3A) . Consistently, when ROS levels (Fig. 2B) . These findings clearly demonstrate cardiomyocytes were exposed to H O (Fig. 3A) , a time- 2 2 that Et-1 treatment to cardiomyocytes increases intracelludependent increase of c-fos mRNA levels was noticed. The lar ROS levels.
H O treatment for 60 min induced c-fos mRNA levels in 2 2 cardiomyocytes about 13-fold as compared with controls 3.2. Inhibitory effect of antioxidants on the expression of (Fig. 3A) . All these results suggest that Et-1-induced c-fos c-fos gene by Et-1 mRNA in cardiomyocytes are modulated through ROS generated during Et-1 exposure. We then investigated whether ROS generated by Et-1
We then examined the effects of antioxidant or free play a role in gene expression. Previous studies demonradical scavenger, i.e. catalase and NAC, on the induction strated that ROS stimulated the expression of immediate of c-fos by Et-1. As shown in Fig. 3B both Et-1 (10 early response genes such as c-fos, c-jun, c-myc and egr-1 nmol / l) and H O (25 mmol / l) increased c-fos mRNA 2 2 [28]. Of these genes, c-fos was found to respond to both levels in cardiomyocytes. However, the addition of catalEt-1 [4, 21] and H O [22] treatment in cardiomyocytes.
ase (350 U / ml) and NAC (10 mmol / l) 30 min prior to the controls induced c-fos mRNA levels about 21-folds as compared with controls (Fig. 3B) . However, the c-fos induction by PMA was only partially inhibited after these pretreatment of cardiomyocytes inhibits this c-fos inducantioxidants treatment (data not shown) indicating that the tion. inhibitory effect of antioxidants was specific for Et-1-induced c-fos gene expression. These findings are con-
ROS modulated Et-1-increased c-fos transcriptional sistent with the earlier results of ROS induction in car-
activity diomyocytes after Et-1 treatment (Fig. 2) . Taken together, these results suggest that Et-1-induced ROS levels are To further determine whether the ROS modulating the involved in the c-fos gene expression since antioxidant Et-1-induced c-fos expression was a transcriptional event, a c-fos promoter activity was examined by using a reporter gene construct containing c-fos promoter region (22.25 kb) and reporter gene chloramphenicol acetyltransferase (CAT). This chimera was transfected into cardiomyocytes followed by Et-1 or H O stimulation. As demonstrated in 2 2 Fig . 4A , either catalase or NAC alone had no effect on the basal c-fos promoter activity. However, cardiomyocytes treated with Et-1 (10 nmol / l) and H O (25 mmol / l) for 2 2 24 h led to a 2.7-and 2.1-fold increase in CAT activity, respectively, as compared to control unstimulated cells (Fig. 4B) . In the presence of catalase (or NAC), Et-1-or H O -induced c-fos promoter activities were significantly 2 2 inhibited. These data clearly indicate that ROS modulate the increase of c-fos promoter activity in cardiomyocytes after Et-1 or H O treatment. 
Ras mediated Et-1-induced ROS generation and cfos expression
Ras has been demonstrated to be involved in the intracellular ROS generation in fibroblasts [20] . In order to study the role of Ras in the Et-1-induced ROS generation, expression plasmid encoding a constitutively activated Ras protein (RasL61) was used to transfect into carras diomyocytes. RasL61 is an active form of p21 in which the Gln-61 in the wild type has been replaced by Leu [25] . As shown in Fig. 5A , RasL61 (5 mg) transfection into cardiomyocytes led to a 4.5-fold increase in intracellular pSRa-transfected cardiomyocytes after Et-1 treatment increased intracellular ROS levels. In contrast, cardiomyocytes transfected with dominant negative Ras mu- nificantly increased the c-fos mRNA (Fig. 5B) . The mmol / l) treatment for 30 min (Fig. 5B) . To further 4. Discussion confirm that Ras mediated Et-1-induced c-fos promoter activity, we cotransfected c-fosCAT reporter gene with
In the present study, we demonstrated that neonatal rat RasL61 (or RasN17). Cotransfections of the c-fosCAT cardiomyocytes exposed to Et-1 increased intracellular reporter gene with RasL61 (5 mg) stimulated c-fosCAT reactive oxygen species and resulted in an induction of activity by 3.8-fold as compared with control pSRa-transc-fos gene expression via Ras pathway. Recent observation fected cells (Fig. 6) . The treatment of catalase 350 U / ml indicates that cells from various sources (i.e. endothelial for 24 h partially inhibited the RasL61 stimulated c-fos cells, smooth muscle cells, etc.) exposed to various growth promoter activity. Cotransfections of the c-fosCAT reportfactors or stimuli generate ROS as second messengers er construct with RasN17 (5 mg) into cardiomyocytes [12] . Present study has clearly demonstrated that carinhibited c-fos promoter activity induced by Et-1 (Fig. 6) .
diomyocytes exposed to Et-1 increase intracellular ROS However, H O (25 mmol / l) treatment for 24 h on levels via Et A receptor-dependent mechanism. This 2 2 cardiomyocytes cotransfected with c-fosCAT and RasN17 finding is consistent with the previous report that the Et A (5 mg) led to 2.2-fold increase in CAT activity as is the main receptor type present in the rat heart [29] and compared to that of RasN17-transfected cells (Fig. 6B) .
cardiomyocytes [30] . Furthermore, the increase of ROS by All these results suggest that Ras mediate ROS generation Et-1 treatment was completely abolished by co-incubation of cardiomyocytes with the antioxidant enzyme catalase. This indicates that H O is a major reactive oxygen 2 2 species that contribute to the increase of c-fos induction in Et-1-treated cardiomyocytes. Catalase is a big molecule which is unlikely to diffuse into cells but appeared to rapidly clear the intracellularly Et-1-induced H O . Be- 2 2 cause H O is relatively stable, the intracellular generated 2 2 H O that is permeable to membrane can be easily 2 2 removed by catalase. Alternatively, the extracellular catalase may be uptake by the cardiomyocytes and results in a decrease of intracellular ROS levels. The uptake of catalase into cells and the decrease of intracellular ROS levels have been previously shown in platelet-derived growth factor (PDGF)-treated smooth muscle cells [31] . Catalase has also been effectively used in treating various cells to prevent from cytokine-or growth factor-induced gene expression [31] [32] [33] . This is also in agreement with our previous report demonstrating the inhibitory effect of catalase on hemodynamic forces-induced gene expression by reducing intracellular ROS levels [34] [35] [36] . The induction of ROS by Et-1 was also blocked by the glutathione (GSH) precursor NAC. NAC treatment raised the levels of intracellular GSH that might remove the intracellular H O 2 2 via GSH peroxidase [11] . Our ROS induction by Et-1 was a time-and dose-dependent phenomenon. The origin of this increased ROS is not clear. ROS, including H O , 8) . Some cells were pretreated transcription factors [12] . In the present study, we used the premise that ROS are generated by Et-1 via a Ras oxidant-inducible gene c-fos as a target gene to demondependent mechanism. Taken together, these results prostrate that this Et-1-induced c-fos expression was an event vide strong evidence for a Ras-based signaling cascade involving intracellular redox changes. Et-1 treatment of linking Et-1 receptors to ROS generation and the activation cardiomyocytes, similar to H O exposure, induced a of the c-fos gene in cardiomyocytes. 2 2 transient increase of c-fos expression. This transient inducWe have previously demonstrated that ROS work as tion by Et-1 was inhibited by treatment of cardiomyocytes second messengers in vascular endothelial cells subjected with catalase or NAC. As a positive control, carto hemodynamic forces [34] [35] [36] . These increased ROS diomyocytes treated with PMA stimulated their c-fos induced AP-1 binding to a cis-acting element (TRE) in the expression. PMA treatment of cardiomyocytes greatly MCP-1 promoter region [34] and possible serum response increased intracellular ROS levels. However, PMA-inelement (SRE) site in the egr-1 promoter region [45] . duced c-fos expression was only partially inhibited by Because c-fos promoter region contains AP-1 and SRE NAC or catalase pretreatment (data not shown). The sites, it is possible that ROS modulate AP-1 and / or SRE immediate proto-oncogene c-fos is normally expressed at a binding via Ras-dependent signaling pathway. The detailed minimal level in the mammalian heart. Increased protomechanisms as to how the ROS modulate the signaling oncogene expression has been implicated in the developpathway remain largely unknown and warrant further ment of cardiac hypertrophy [38] . Induction of c-fos, a study. Nevertheless, this study demonstrates that ROS act transcription factor that interacts with cis-regulatory eleas cellular signals in Et-1-treated cardiomyocytes. The ment AP-1 in many genes, has important consequences for important role of Et-1 for cardiac hypertrophy has been downstream gene expression that may determine the well documented [2, 3] . Because Et-1 induces ROS that phenotypic response to Et-1. The c-fos promoter region result in c-fos induction which subsequently may regulate contains at least three cis-regulatory regions that are the expression of late genes, the suppression of intracelluinvolved in the regulation of c-fos transcription; i.e., the lar redox changes by increasing antioxidant capability may SIE (sis-inducible element), AP-1 (Fos-Jun transcription provide some insight for preventing Et-1-induced gene factor complex) and the SRE (serum responsive element) alterations in cardiomyocytes during the development of [39] . The activation of c-fos transcription is thought to be cardiac hypertrophy. Improvement of myocardial redox mediated by the activation of MAPK [40] . It has also been status with vitamin E therapy that can attenuate the demonstrated that H O is capable of stimulating MAPK development of hypertrophy to heart failure has recently 2 2 [41, 42] . In cardiomyocytes, Et-1 has been shown to been reported [46] . Our results provide further support of activate two closely related MAPK isoforms, p42MAPK the importance of ROS as second messenger for Et-1-and p44MAPK [43] via a Ras-dependent pathway. Recent induced responses in cardiovascular systems. This finding data even indicate that Ras is a common signaling target of may offer clinical implications for the therapeutic potential ROS [44] . Thus, Et-1-induced ROS are likely to activate of antioxidant treatment against the transition from comthe signaling pathway that results in the induction of pensatory hypertrophy to heart failure. transcriptional activity of c-fos.
Our results further demonstrated that Ras was involved in Et-1-induced ROS generation because a proportional
